The Role of Dopamine Agonists in Pituitary Adenomas.
Sign Up to like & getrecommendations! Published in 2020 at "Endocrinology and metabolism clinics of North America"
DOI: 10.1016/j.ecl.2020.05.006
Abstract: Dopamine agonist therapy is the primary therapy for prolactin-secreting adenomas and usually results in normoprolactinemia, eugonadism, and tumor reduction. Cabergoline is superior to bromocriptine with regard to efficacy and tolerance. Withdrawal of cabergoline can be… read more here.
Keywords: dopamine agonists; agonists pituitary; pituitary adenomas; cabergoline ... See more keywords